Daniel Munblit - Infectious Diseases

Author Information

D. Munblit is affiliated with the Department of Paediatrics and Paediatric Infectious Diseases at the Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University) in Moscow, Russia. His work primarily focuses on pediatric healthcare, with a significant interest in infectious diseases and post-COVID-19 conditions. His research contributes to understanding the implications of infectious diseases, particularly in children, and the long-term outcomes associated with COVID-19.

Research Contributions

D. Munblit has made substantial contributions to the field of infectious diseases, particularly focusing on post-COVID-19 conditions in both children and adults. His work involves examining the clinical characteristics, mental health issues, and risk factors associated with long COVID. Additionally, he has been involved in developing core outcome sets to improve research and clinical practices related to post-COVID-19 conditions. His studies have also explored broader topics such as the burden of non-communicable diseases among adolescents and the relationship between blood eosinophil levels and asthma development in early childhood.

Aliases

D. Munblit is also known by the aliases D Munblit and Daniel Munblit. These variations of his name are used across different publications and platforms.

Publication and Citation Metrics

Metric	Value
Total Papers	83
Total Citations	3483
h-index	31

Publications:

Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children.

DOI: 10.2217/fmb-2021-0285

Year: 2022

Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development

DOI: 10.1186/s12916-021-02222-y

Year: 2022

Changes in blood eosinophil levels in early childhood and asthma development: A case‐control study

DOI: 10.1111/pai.13734

Year: 2022

Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019.

DOI: 10.1016/s2352-4642(22)00073-6

Year: 2022

Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol

DOI: 10.3389/fped.2022.834875

Year: 2022

Prevalence and Risk Factors of Post-COVID-19 Condition in Adults and Children at 6 and 12 Months After Hospital Discharge: A Prospective, Cohort Study in Moscow (Stop COVID)

DOI: 10.2139/ssrn.4020142

Year: 2022

Core Outcome Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID): An International Delphi Consensus Study ‘PC-COS’

DOI: 10.2139/ssrn.4017375

Year: 2022

Long-term outcomes of pediatric infections: from traditional infectious diseases to long covid

DOI: 10.2217/fmb-2022-0031

Year: 2022

Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting

DOI: 10.1007/s00403-022-02341-3

Year: 2022

Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study

DOI: 10.1183/13993003.01341-2021

Year: 2022

What Research is Being Conducted?

Are There Concerns About Antiviral Resistance?

How is HSV Diagnosed?

How is Colonization Managed or Treated?

What are Common Adverse Effects of Antimicrobial Drugs?

What are the Global Health Implications?

How Do B Cells Recognize Pathogens?

Why are Zoonotic Diseases Important?

What is Yellow Fever?

How is Drug Toxicity Measured?

Partnered Content Networks

Relevant Topics